CTRI/2020/12/029529Not yet recruitingPhase 1
The evaluation of imaging modality to determine the ideal treatment modalities in patients with TMJ Dislocation- A prospective clinical study - CBCT- TMJD
OGITHA SRI S0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 1
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
Inclusion Criteria
- •1)Patients with TMJ Dislocation into study group and normal into control group
- •2)No previous TMJ surgeries
Exclusion Criteria
- •1)Patient with previous history of TMJ surgery
- •2)Patient with age <18 and >50
Investigators
Similar Trials
Recruiting
Not Applicable
Evalutation of the patients with localized stricture of MPD without obvious mass in the pancreasPatients with localized MPD stricture without obvious mass in pancreasJPRN-UMIN000039623Kitano Hospital, Tazuke Kofukai Medical Research Institute.30
Active, not recruiting
Phase 1
Phase 2a open label study of Fovista¿ (anti-PDGF agent) administered in combination with anti-VEGF therapy in subjects previously treated or treatment-naive.Subfoveal choroidal neovascularization secondary to Age-Related Macular Degeneration (AMD)MedDRA version: 20.0Level: PTClassification code 10071129Term: Neovascular age-related macular degenerationSystem Organ Class: 10015919 - Eye disordersMedDRA version: 20.1Level: LLTClassification code 10067791Term: Wet macular degenerationSystem Organ Class: 10015919 - Eye disordersEUCTR2015-000519-42-ITIVERIC bio, Inc.32
Active, not recruiting
Phase 1
Role of imaging in the evaluation of anatomic alterations in neovascular Age-Related Macular Degeneration (AMD) subjects: 18 month study of Fovista® (anti-PDGF therapy) administered in combination with anti-VEGF therapySubfoveal choroidal neovascularization secondary to Age-Related Macular Degeneration (AMD)MedDRA version: 18.0 Level: PT Classification code 10071129 Term: Neovascular age-related macular degeneration System Organ Class: 10015919 - Eye disordersMedDRA version: 18.0 Level: LLT Classification code 10067791 Term: Wet macular degeneration System Organ Class: 10015919 - Eye disordersEUCTR2015-000519-42-FROPHTHOTECH CORPORATIO32
Recruiting
Not Applicable
AI-based imaging diagnostic systems for rectal cancerrectal cancerlarge intestine, rectumD012004JPRN-jRCT1040210050Ouchi Akira200
Active, not recruiting
Phase 1
Amyloid imaging in Alzheimer’s disease, frontotemporal dementia and healthy volunteersse of 18F-AV-45 positron emission tomography as early diagnostic technique in frontal lobe dementia and Alzheimer's disease.MedDRA version: 14.0 Level: PT Classification code 10061816 Term: Diagnostic procedure System Organ Class: 10022891 - InvestigationsEUCTR2008-003597-18-GBAvid Radiopharmaceuticals, Inc34